相关实验视频
Updated: Jan 11, 2026

06:09
An In Ovo Model for Testing Insulin-mimetic Compounds
Published on: April 23, 2018
11.1K
优化2型糖尿病治疗的新方法:分类的重要性
María José Reyes-Medina1,2,3, Vanesa Cantón-Habas1,2,3, Francisco Javier Sánchez-Jiménez1,2,3
1Department of Nursing, Pharmacology and Physiotherapy, Faculty of Medicine and Nursing, University of Córdoba, Córdoba, Spain.
Frontiers in endocrinology
|November 19, 2025
概括
通过将患者分为七个病理生理学子组,可以优化2型糖尿病 (T2DM) 的管理. 以此次分类为指导的个性化治疗策略可以改善患者的治疗结果并减少并发症.
科学领域:
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
- 药理学 药理学 是一个学科.
背景情况:
- 2型糖尿病 (T2DM) 仍然是微血管和宏血管并发症的主要原因,尽管诊断和治疗方面取得了进展.
- 目前的治疗策略往往缺乏个性化,这可能会限制治疗的有效性.
研究的目的:
- 探索基于患者病理生理学的T2DM分类的实用性.
- 在临床实践中评估病理生理学分类的实施情况.
- 评估个性化治疗替代方案,以优化T2DM管理.
主要方法:
- 关于T2DM病理生理学和治疗的现有文献的全面审查.
- 开发一种新的算法,用于T2DM的分层诊断分类.
- 在拟议的患者子组中分析口服抗糖尿病药物的疗效.
主要成果:
- 患有T2DM的患者可以分为七个不同的病理生理学子组.
- 治疗疗效在各个子组之间有所不同,这表明需要个性化方法.
- 甲胺被确定为普遍推的第一线药物.
结论:
- 基于病理生理学的T2DM分类使得量身定制的治疗策略成为可能.
- 个性化医疗方法可以优化T2DM管理并减轻并发症.
- 具体的药物类别显示不同的疗效,取决于患者的子组形状.
相关概念视频
Diabetes: Management and Pharmacotherapy
851
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
851
Diabetes Mellitus: Overview and Type I Subtype
4.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Carbohydrate Metabolism
13.7K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
13.7K
Therapeutic Drug Monitoring: Overview and Classification
279
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
279
Oral Hypoglycemic Agents: Biguanides and Glitazones
567
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
567

